These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 19438733)

  • 1. Rejection and acceptance of possible side effects of migraine prophylactic drugs.
    Kowacs PA; Piovesan EJ; Tepper SJ
    Headache; 2009 Jul; 49(7):1022-7. PubMed ID: 19438733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and determinants of migraine prophylactic medication in the Netherlands.
    Rahimtoola H; Buurma H; Tijssen CC; Leufkens HG; Egberts AC
    Eur J Clin Pharmacol; 2002 May; 58(2):149-55. PubMed ID: 12012149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prophylactic treatments of migraine].
    Massiou H
    Rev Neurol (Paris); 2000; 156 Suppl 4():4S79-86. PubMed ID: 11139754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients' preference for migraine preventive therapy.
    Peres MF; Silberstein S; Moreira F; Corchs F; Vieira DS; Abraham N; Gebeline-Myers C
    Headache; 2007 Apr; 47(4):540-5. PubMed ID: 17445103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventive treatment of migraine: effect on weight.
    Young WB; Rozen TD
    Cephalalgia; 2005 Jan; 25(1):1-11. PubMed ID: 15606563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weight change associated with the use of migraine-preventive medications.
    Taylor FR
    Clin Ther; 2008 Jun; 30(6):1069-80. PubMed ID: 18640463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of disease features on adherence to prophylactic migraine medication.
    Linde M; Jonsson P; Hedenrud T
    Acta Neurol Scand; 2008 Dec; 118(6):367-72. PubMed ID: 18513346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Divalproex sodium in the treatment of migraine and cluster headaches.
    Gallagher RM; Mueller LL; Freitag FG
    J Am Osteopath Assoc; 2002 Feb; 102(2):92-4. PubMed ID: 11866398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prophylactic drug management of migraine].
    Göbel H; Heinze A
    Schmerz; 2002 Jun; 16(3):223-40. PubMed ID: 12077682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Migraine prevention: what patients want from medication and their physicians (a headache specialty clinic perspective).
    Rozen TD
    Headache; 2006 May; 46(5):750-3. PubMed ID: 16643577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features and pharmacological treatment of migraine patients referred to headache specialists in Canada.
    Jelinski SE; Becker WJ; Christie SN; Giammarco R; Mackie GF; Gawel MJ; Eloff AG; Magnusson JE
    Cephalalgia; 2006 May; 26(5):578-88. PubMed ID: 16674767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A migraine prophylaxis educational intervention in a Medicaid population.
    Owens C; Pugmire B; Owens K
    Headache; 2008 Feb; 48(2):267-71. PubMed ID: 18194289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerance and loss of beneficial effect during migraine prophylaxis: clinical considerations.
    Loder EW; Rizzoli P
    Headache; 2011 Sep; 51(8):1336-45. PubMed ID: 21884088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective prophylactic treatments of migraine lower plasma glutamate levels.
    Ferrari A; Spaccapelo L; Pinetti D; Tacchi R; Bertolini A
    Cephalalgia; 2009 Apr; 29(4):423-9. PubMed ID: 19170689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of propranolol in the treatment of migraine].
    Klimek A; Nevodnichiĭ A
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(1):75-8. PubMed ID: 7064609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Shuhendler AJ; Lee S; Siu M; Ondovcik S; Lam K; Alabdullatif A; Zhang X; Machado M; Einarson TR
    Pharmacotherapy; 2009 Jul; 29(7):784-91. PubMed ID: 19558252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use and overuse of antimigraine drugs by pharmacy personnel in France: COTA survey.
    Donnet A; Lantéri-Minet M; Aucoin F; Allaf B
    Headache; 2009 Jul; 49(7):1014-21. PubMed ID: 19486362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible precipitation of migraine attacks with prophylactic treatment.
    Donnet A; Vuillaume De Diego E; Lanteri-Minet M
    Eur Neurol; 2009; 61(1):23-6. PubMed ID: 18948696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Migraine treatment.
    Becker WJ; Gawel M; Mackie G; South V; Christie SN
    Can J Neurol Sci; 2007 Nov; 34(4):S10-9. PubMed ID: 18062466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevalence of primary headaches in a rural population in Cuba].
    Quesada-Vázquez AJ; Contreras-Maure LJ; Alvarez-Aliaga A; Traba-Tamayo ER
    Rev Neurol; 2009 Aug 1-15; 49(3):131-5. PubMed ID: 19621307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.